Blog: Shayna Slater, Anapol Weiss Partner

Shayna Slater is a leader in the Women's Health Litigation Team and the firm's Unsafe Drug & Medical Device Team. She concentrates her practice on mass torts, product liability, and other civil litigation.

Possible Olympus Scope Case? Consider These Steps

Apr 21, 2026

Anapol Weiss is currently investigating infection claims caused by certain Olympus scope devices. These devices, commonly used during endoscopy procedures, have been linked to serious infections due to alleged design and sterilization issues. If you or a loved one underwent a procedure involving an Olympus scope and developed an infection, you may want to consider your next steps. 1. Pay Attention to Symptoms and Diagnosis Post-procedure infections resulting from contaminated Olympus scopes often involve antibiotic-resistant bacteria which can...

How Olympus Scopes Could Lead to Nationwide Infection Outbreaks

Apr 20, 2026

Olympus Scopes Infection Risk: Why Are Reusable Endoscopes Linked to Serious Outbreaks Across U.S. Hospitals? In hospitals across the United States, reusable Olympus scopes have been linked to serious infection outbreaks. While these devices play a crucial role in many common diagnostic procedures, their design and use have raised serious health concerns. Reusable Olympus Scopes: How Does Their Design Create Infection Risks for Patients? Olympus scopes are specialized endoscopic devices utilized in common gastrointestinal procedures. Each year these...

The Depo-Provera MDL: Where Things Stand

Oct 17, 2025

Depo Provera, a long-acting injectable contraceptive containing depot medroxyprogesterone acetate (DMPA), was approved by the FDA in 1992. However, studies have linked prolonged DMPA use to an increased risk of developing intracranial meningiomas. While the majority of intracranial meningiomas are benign, they often require extensive surgical intervention and can result in significant complications. These findings have led to litigation and scrutiny of Pfizer's actions surrounding the safety of the drug. Women who were administered Depo Provera...

Depo Provera Litigation Update

Jun 23, 2025

Depo Provera, a long-acting injectable contraceptive containing depot medroxyprogesterone acetate (DMPA), was approved by the FDA in 1992. Since its approval, it has been widely used due to its convenience. However, recent medical studies have uncovered a troubling correlation between prolonged DMPA use and an increased risk of intracranial meningiomas. While the majority of intracranial meningiomas are benign, they often require extensive surgical intervention and can result in significant complications. These findings have led to...

Upcoming JPML Hearing on Depo-Provera Litigation: A Critical Step Toward Consolidation

Jan 21, 2025

In the world of pharmaceutical litigation, a multidistrict litigation (MDL)—as the ongoing Depo Provera lawsuit 2024 is poised to become—is often a critical tool for efficiently managing and consolidating lawsuits involving similar issues or claims. The upcoming hearing by the Judicial Panel on Multidistrict Litigation (JPML) on January 30, 2025, will address the potential formation of an MDL to handle the growing number of lawsuits related to the injectable contraceptive Depo-Provera. Depo-Provera, marketed by Pfizer under...

How to Sign Up for the Depo-Provera Lawsuit 2024

Nov 23, 2024

If you or a loved one has been diagnosed with meningioma after using Depo-Provera, you may be entitled to pursue legal action. Anapol Weiss, a nationally recognized personal injury law firm, has long been a leader in mass tort claims against some of the largest pharmaceutical companies, including Johnson & Johnson and Pfizer. In October, Anapol Weiss filed the Depo-Provera lawsuit 2024, one of the first complaints specifically alleging that Depo-Provera, manufactured by Pfizer, caused...

Advocacy with Empathy: The Power of Female Attorneys Representing Female Clients

Nov 13, 2024

As a female lawyer who is also a mom to two amazing boys, it quickly became apparent that the juggling act between career and motherhood would be difficult. As a mother, my priorities shifted, and I quickly realized that if I was going to maintain my career, I had to be passionate about what I was doing. At that time, litigations began emerging that solely or disproportionately affected women. In speaking to women who were...

Could Tumors Caused by Depo-Provera Have Been Avoided by a Safer Version Owned by Pfizer?

Oct 5, 2024

Shayna Slater, Anapol Weiss Women’s Health Ligitation Team Depo-Provera, a popular hormonal contraceptive, has been a go-to choice for many seeking birth control. Administered via injection every three months, it purported to offer convenience and effectiveness. However, there is now evidence that it also increased women’s risk of brain and spinal tumors, called meningiomas. A Safer Alternative Sadly, initial research suggests that Pfizer actually owned a safer alternative. While investigation continues, if Pfizer did, in fact, own a...

Depo-Provera and Brain and Spinal Cord Tumors (Meningiomas): What you Need to Know

Sep 17, 2024

When it comes to managing birth control, women have numerous options available to them, from oral contraceptives to long-acting methods like Depo-Provera. Depo-Provera, an injectable form of birth control, has been a popular choice due to its convenience and efficacy. However, a recent study linked Depo Provera use to an increased risk of brain and spinal tumors called meningiomas. It is estimated that 1 in 5 women have used Depo-Provera at some point which makes...

The Presence of Metals in Tampons: What You Need to Know

Sep 13, 2024

In August 2024, a study conducted by UC Berkely looked at 16 different metals in various tampon brands and product lines. This was the first study of its kind to investigate metals in tampons and unfortunately it returned some concerning results that have women on edge. The study tested for arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium and zinc. The tampons had measurable concentrations of all 16...